Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year, private-label deal with Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX).
Under the terms of the agreement, Vancouver-based Angiotech will supply Hologic with its soft tissue biopsy device for breast biopsies. The deal is specific for products sold in the U.S. and will automatically renew after thee years, according to Angiotech.